Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin With or Without ZD 1839 in Advanced Colorectal Carcinoma
NCT00026299Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Sep 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in colorectal cancer (CRC), sponsored by University of Chicago. Started Sep 2001; status: completed.
02
Drugs
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00026299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026299.